BASILIXIMAB

Drug action

Basiliximab is a monoclonal antibody that acts as an interleukin-2 receptor antagonist and prevents T-lymphocyte proliferation.

Indications and dose

Prophylaxis of acute rejection...

This item requires a subscription.
For full access to this content, log in to an existing user account or purchase an individual subscription.
×
Sign in or create an account
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. Sign in or purchase a subscription to access this content. ×